AAAS member Satoshi Omura awarded 2015 Nobel Prize in Physiology or Medicine Monday, October 5, 2015 The Nobel Prize in Physiology or Medicine 2015 was awarded jointly to William C. Campbell and Satoshi Omura for their discoveries concerning a novel therapy against infections caused by roundworm parasites and to Youyou Tu for her discoveries concerning a novel therapy against Malaria. Omura is a professor emeritus at Kitasato University, Japan and member of AAAS. Phil Collins, professor of physics and astronomy at UC-Irvine Phil Collins develops tiny wire 'bugs' to study molecular behavior Member Spotlight June 5, 2015 Long before the nanotech frenzy kicked in, AAAS Fellow Phil Collins was thinking about studying "tiny wires." Now, 30 years after he started toying with the idea, the rise of nanotechnology is creating novel research partnerships, as biologists, engineers—and physicists—seize on its vast possibilities for molecular research. Can Congress now take on antibiotic resistance? Capitol Connection May 4, 2015 As a child, U.S. Rep. Louise Slaughter (D-NY) lost her sister Virginia to pneumonia. Deeply affected by this loss, she chose to pursue degrees in microbiology and public health. Since 1999, Slaughter has put her knowledge in these fields to work in efforts to pass legislation designed to curb a frightening increase in antibiotic-resistant bacteria. With public sentiment shifting on this topic, does she finally have a shot? Elisabet de los Pinos: Growing a startup from scratch, with help from a postdoc Biotech pioneer innovates startup workplace with help from postdoc Driving Force August 6, 2015 Elisabet de los Pinos, Ph.D.Founder and CEOAura Biosciences, Cambridge, MA Background:Molecular biologist Elisabet de los Pinos was just 37 when she had the novel idea to use viral proteins to deliver cancer-killing drugs directly to tumor cells—to enhance the efficacy and reduce the toxic side effects of traditional chemotherapies. To sound out her theory, she turned to the world’s top virologists, who encouraged her to develop the technology. Cancer research award application deadline March 15 Cancer research award application deadline March 15 Monday, March 2, 2015 Attention young cancer researchers: the application deadline for the prestigious 2015 AAAS Martin and Rose Wachtel Cancer Research Award has been extended to 15 March, 2015. AAAS member Arthur Upton, expert in radiation effects on human health, dead at 91 Friday, February 27, 2015 AAAS member Dr. Arthur Canfield Upton died on February 14. He was 91. Upton was internationally recognized for his research on the health effects of ionizing radiation and other hazardous environmental agents. Will a name change make NIH research center less controversial? Capitol Connection February 19, 2015 A controversial National Institutes of Health center has a new name. The National Center for Complementary and Alternative Medicine (NCCAM) is now the National Center for Complementary and Integrative Health (NCCIH). Could a name change help give the center more credibility? NIH prize challenges innovators to 'Follow That Cell' NIH prize challenges innovators to 'Follow That Cell' Wednesday, November 5, 2014 The National Institutes of Health is challenging science innovators to compete for prizes totaling up to $500,000, by developing new ways to track the health status of a single cell in complex tissue over time. The NIH Follow that Cell Challenge seeks tools that would, for example, monitor a cell in the process of becoming cancerous, detect changes due to a disease-causing virus, or track how a cell responds to treatment. AAAS BOO-LECULAR STENCIL – Test Tubes AAAS boo-lecular stencil – Test Tubes Download October 30, 2014 IT'S PUMPKIN CARVING TIME! This Halloween, show your love for Science with a AAAS pumpkin carving stencil. Free to download now! Could an open-access database speed up drug development? Could an open-access database speed up drug development? Capitol Connection October 6, 2014 A recent study finds a significant logjam in the development of new drugs at the discovery and early preclinical phases. Could the creation of an open-source translational research database help solve the problem?